Survey shows that women frequent pharmacy based on convenience, location
WESTERVILLE, Ohio As many as 68% of women choose a pharmacy based on convenience/location, compared with only 48% of men, according to the Winter 2009 Ad-ology Media Influence on Consumer Choice survey released Wednesday.
Women prefer to fill prescriptions at a grocery store pharmacy, with more than twice as many females than males saying loyalty programs and rewards are “very important.”
Overall, 53% of pharmacy customers still prefer to fill their prescriptions at a drug store, versus at a grocery store or online.
“Grocery stores have been successful getting women into their pharmacies,” stated Lee Smith, president and CEO of Ad-ology Research. “There’s opportunity for other pharmacies to attract this demographic by highlighting convenience and their own rewards programs – especially online.”
Although most customers prefer to refill prescriptions offline, many are influenced by online content. Almost 1-in-5 reported that a store/pharmacy Web site provided “significant” or “some” influence on their choice of which pharmacy to use, with slightly more males than females influenced by store/pharmacy Web sites. Social media also was an influence: positive comments/reviews from other shoppers influenced 20% of customers.
Other key findings from the survey:
- In the last year, nearly half of pharmacy customers 65 years old and older initiated a conversation with their doctor about a specific brand of medication
- Out-of-pocket costs, knowledgeable pharmacists, and availability of generic medications are the most significant factors when selecting a pharmacy
- Hispanics more than other ethnic groups prefer filling prescriptions at drug stores (72.7%)
- Slightly more males than females were influenced by store/pharmacy web sites
- Of traditional media types, newspapers (21.8%) and television (20.1%) had the most influence on pharmacy choice
The Media Influence on Consumer Choice survey is conducted quarterly by Ad-ology Research to study on- and off-line media influence on buying decisions.
New supplement designed for weight-loss surgery patients
ST. LOUIS Undergoing weight-loss surgery means making sacrifices, particularly in the area of food, but this can sometimes place patients at risk for vitamin and mineral deficiencies. A company in St. Louis, however, has created a prescription nutritional supplement for patients who have undergone the surgery.
ProBarimin QT, made by Fleming Pharmaceuticals, is a fruit-flavored supplement that dissolves in the mouth.
“Although there are over-the-counter supplements for WLS patients, ProBarimin QT is specially formulated to meet the unique nutritional and intake requirements of WLS patients,” Fleming president Phill Dritsas said.
The supplement includes vitamins such as B12, C and D and minerals such as iron, selenium and zinc.
The patent for the supplement is pending.
New lab test determines if aspirin is effective for heart attack, stroke prevention
DENVER Corgenix Medical on Tuesday introduced a laboratory test in the Wichita, Kan., area that determines if the aspirin being taken to prevent a heart attack or stroke is effective.
The AspirinWorks Test is available to doctors across Kansas through AMS Laboratory. Edwin Harned, AMS Laboratory president and CEO, said he’s excited to field a test that gives physicians a tool to identify patients who are not benefiting from their aspirin therapy.
“Any time we have the chance to offer a test that gives the physician and patient good information about the validity of a drug that they are taking, we think it’s a great test,” Harned said.
The AspirinWorks Test determines the effect of aspirin on platelets by measuring the level of the biomarker called thromboxane B2. The higher the levels of thromboxane B2, the stickier the blood platelets, and the less impact the aspirin is having. This information allows physicians to individualize a patient’s therapy, which may be as simple as adjusting the dose.
“Not everyone responds the same to the same dose of aspirin,” noted Gordon Ens, clinical affairs director for Corgenix Medical. “So we came up with a simple, non-invasive test to measure aspirin effect in individuals taking aspirin to reduce the risk of a heart attack and stroke.”
AspirinWorks is the only FDA-cleared test that measures urinary thromboxane B2 to accurately determine aspirin effect in apparently healthy individuals. Unlike other platelet tests, which require freshly drawn blood that must be evaluated within four hours, the AspirinWorks Test only requires a urine sample that can be obtained at the doctor’s office or AMS Laboratory patient service centers.
The AspirinWorks Test is reimbursed by most insurance carriers, and covered under Medicare and Medicaid, the company stated.